Media

Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies

VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease

Fusion Pharmaceuticals And TRIUMF Announce Expanded R&D Collaboration For Actinium Supply Production

Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations

Invitation to presentation of the Q2 2021 results

Aprea Therapeutics Announces Clinical Hold on Lymphoid Malignancy Program

Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates

Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results And Business Update

Aprea Therapeutics Announces a Partial Clinical Hold on Myeloid Malignancy Programs

Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update